July 15, 2026- In an era defined by supply chain disruption, labor shortages, and rising pressure on global manufacturing networks, the question of where – and how – medical products are made has become central to industry resilience. Few companies illustrate the “Made in America” manufacturing conversation as clearly as Aspen Surgical, which has doubled down on a vertically integrated, North American-based production model to maintain stability and quality in a volatile environment.
At the center of Aspen Surgical’s strategy is a structured footprint anchored in Caledonia, Michigan, complemented by additional U.S. manufacturing in Las Piedras, Puerto Rico, and nearshore operations in Agua Prieta, Mexico. The company also extends its global reach with instrumentation manufacturing in Tuttlingen, Germany, and commercial and distribution operations in Melbourne, Australia – allowing it to stay close to customers while retaining end-to-end control of critical processes, from injection molding and blade stamping to assembly and packaging.
That localized control proved valuable when global supply chains buckled, enabling Aspen Surgical to maintain service levels without sacrificing quality or growth. In 2023, the company reinforced its long-term commitment with a $5 million investment to expand its Caledonia headquarters, consolidating distribution operations, adding 131,000 square feet of capacity, and creating up to 75 manufacturing and distribution jobs in West Michigan.
Continue Reading in the latest issue of Repertoire Magazine.
Sponsored – Aspen Surgical